Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
With over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications.
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
With deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
Get a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Recombinant human antibody to Human MSLN. Anetumab ravtansine is a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect.
Type
IgG1 - lambda
Species Reactivity
Human
Expression Host
CHO
Applications
Suitable for use in FC, IP, ELISA, Neut, FuncS, IF, WB and most other immunological methods.
Uses Immunogen TAP technologygamma1 heavy chain (1-450) [Homo sapiens VH (IGHV5-51*01 (94.90%) – (IGHD) – IGHJ4*01) [8.8.13] (1-120) -IGHG1*01 (CH1 (121-218), hinge(219-233), CH2 (234-343), CH3 (344-448), CHS (449-450)) (121-450)], (223-216') – disulfide withlambda light chain (1'-217') [Homo sapiens V- LAMBDA (IGLV2-14*01 (95.60%) – IGLJ2*01) [9.3.11] (1'-111') – IGLC2*01 A43>G (155) (112'-217')]; dimer (229-229'':232-232'') – bisdisulfide;conjugated, on an average of 3 lysyl, to maytansinoid DM4 [N2'-deacetyl-N2'-(4-mercapto-4-methyl- 1-oxopentyl)-maytansine] via thereducible SPDB linker [N-succinimidyl 4-(2-pyridyldithio)butanoate]
Purity
Purity >95% by SDS-PAGE.
BACKGROUND
Antigen Description
This gene encodes a protein with similarity to follistatin, an activin-binding protein. It contains an FS module, a follistatin-like sequence containing 10 conserved cysteine residues. This gene product is thought to be an autoantigen associated with rheumatoid arthritis.